151 Allosteric MEK inhibitor BAY 86-9766 (RDEA119) shows anti-tumor efficacy in mono-and combination therapy in preclinical models of hepatocellular carcinoma and pancreatic cancer
暂无分享,去创建一个
Robert Schmieder | A. Adjei | K. Ziegelbauer | D. Mumberg | J. Miner | F. Puehler | M. Kissel | A. Scholz | Marion Hitchcock